Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oppenheimer

Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16

Oppenheimer has decided to maintain its Outperform rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) and lower its price target from $20.00 to $16.00. Shares of BioCryst Pharmaceuticals are trading down 1.62% over the last 24 hours, at $10.94 per share.

Why Zeta Global Shares Are Surging Today

Why Zeta Global Shares Are Surging Today

Oppenheimer analyst Brian Schwartz upgraded Zeta Global Holdings Corp (NYSE:ZETA) to Outperform from Perform with a $20 price target (49.5% upside). Zeta is an omnichannel data-driven cloud platform offering enterprises with consumer intelligence and marketing automation software. Schwartz saw a "substantial upside from current prices" based on valuation, improving fundamentals, and transparency. Zeta's revenue growth…

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Oppenheimer Upgrades This Rural Lifestyle Retailer

Oppenheimer analyst Brian Nagel upgraded Tractor Supply Co (NASDAQ:TSCO) to Outperform from Perform with a $270 price target, implying a 16.1% upside. The analyst notes Tractor Supply's model strengthened through the COVID-19 crisis. Nagel specifies that macro tailwinds like soaring fuel prices and demographic shifts as the reasons for the upgrade. Also Read: Tractor Supply Q4…

Does Coinbase Carry A 'Hidden Value' In $6.6B Ventures Business?

Coinbase Global Inc (NASDAQ: COIN) has hidden value that is yet to be realized through its Ventures business, according to Oppenheimer analysts, CoinDesk reported on Monday.

Here's Why Magnite, Digital Turbine, Trade Desk Shares Are Trading Lower Today

Shares of adtech companies fell on Wednesday morning on a report that Alphabet Inc's (NASDAQ:GOOG) (NASDAQ:GOOGL) Google will stop cross-app tracking on Android phones, following a similar move by Apple Inc (NASDAQ:AAPL). "We don't think there should be a forced choice between privacy and developers building their business," Anthony Chavez, VP of product management for Android…

Read How Analysts Reacted To Alteryx's Q4 Results

Analysts had mixed opinions on Alteryx Inc (NYSE:AYX) post Q4 beat. Alteryx is a software company that provides self-service data analytics software. Oppenheimer analyst Ittai Kidron lowered the firm's price target on Alteryx to $85 from $105 (62.9% upside) to reflect multiple realignments while keeping an Outperform rating on the shares. The analyst notes Alteryx's Q4…

inkl

Read news from The Economist, FT, and more,
with one subscription

Oppenheimer Upgrades This Theme Park Company

Oppenheimer Upgrades This Theme Park Company

Oppenheimer analyst Ian Zaffino upgraded Six Flags Entertainment Corp (NYSE:SIX) to Outperform from Perform with a $54 price target, implying a 32.78% upside. The analyst believes the company's newly-appointed CEO Selim Bassoul's strategy of "premiumization" is the right one. The company has been focused on attendance growth for too long and has neglected obvious pricing…

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wall Street Journal

Urban Outfitters

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play